Latest

Latest immunotherapy News | Page 9

  • Latest immunotherapy news stories and updates. What is happening today? All recent immunotherapy news and developments. Live coverage and timeline of immunotherapy. All you need to know about immunotherapy.
Research Advisory Board Welcomes Professor Cameron Turtle
Ludwig Institute Board Member Jedd Wolchok elected to National Academy of Medicine
New approaches to blood and liver cancer therapies recognised with $2.5 million CSL Centenary Fellowships
AstraZeneca advances scientific leadership across multiple cancers with first data from four pivotal Phase III trials at ESMO
Fall allergies: Ragweed and mold are in air
Study shows how brain tumors make certain immune cells turn traitor
Combination therapy promising against ‘cold’ breast cancer tumors
Combination of personalized cancer vaccine and adoptive T cell therapy benefits patients with advanced ovarian cancer
Disrupting a core metabolic process in T cells may improve their therapeutic efficacy
How do hay fever treatments actually work? And what’s best for my symptoms?
£½ million funding announced to find new treatment for oesophageal cancer
Enhertu recommended for approval in the EU by CHMP for patients with HER2-mutant advanced non-small cell lung cancer
Imugene secures new patent in Japan for PD1-Vaxx clinical drug candidate
Veronica’s Finding light beyond storm
BCNA welcomes decision to recommend Keytruda for subsidy for early-stage breast cancer
Mater Researcher’s lymphoma studies attract funding boost
Ludwig Lausanne study illuminates a potentially exploitable coordination of gene expression across the tumor microenvironment
Vital boost to blood cancer treatment
Is it Allergies or Something Else?
Daffodil Day appeal is raising much needed funds
HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I Clinical Trial Agreement
World-first clinical trial for blood cancer underway in the Illawarra
Immune cells in single file
International collaboration to fund breakthrough research to shape the future of precision medicine
Gaining insight into the potential of cannabis in combating viral infections
Donation allows scientists to explore asbestos treatments
Capivasertib in combination with Faslodex granted Priority Review in the US for patients with advanced HR-positive breast cancer
Ludwig Cancer Research study shows certain blood pressure drugs could boost the efficacy of cancer immunotherapy
Datopotamab deruxtecan combinations showed encouraging tumour responses in patients with advanced non-small cell lung cancer in TROPION-Lung02 Phase Ib trial
Lynparza and Imfinzi combination reduced risk of disease progression or death by 37% vs. chemotherapy and bevacizumab in patients with advanced ovarian…
Memory killer cells can improve survival for melanoma patients
Improving Immune Checkpoint Inhibitors’ Anti-tumor Response and Minimizing Side Effects
Life Now participant finds mental and physical benefit from exercising during cancer treatment
Ludwig Chicago study identifies potentially new strategy for combination radio- and immunotherapy
Imfinzi plus Lynparza and Imfinzi alone both significantly improved progression-free survival in advanced endometrial cancer when added to chemotherapy
AstraZeneca will highlight momentum of practice-changing cancer medicines across its robust pipeline at ASCO 2023
Supercharged brain cancer treatment advances to clinical trial
Four common palliative care myths 23 May
Ludwig Oxford’s Yang Shi elected to the Academy of Medical Sciences
Positive results for Immutep’s cancer candidate in combination with MSD’s Keytruda
CAR-NKT cell therapy shows promising results against neuroblastoma in phase 1 clinical trial
Mater Research Celebrates International Nurses Day
SAiGENCI recruit recognised with prestigious award
Funding boost advances research on cancer vaccine
Advanced immunotherapy treatment may hold promise for children with brain cancer
Breast cancer tumors disrupt the immune system remotely favoring their own growth
Merriwa champion becomes face of new cancer research appeal
First patient on trial in colorectal, gastric and ovarian cancer study

© 2026 - The National Tribune Australia